Mesenchymal stem cells in rheumatoid synovium: Enumeration and functional assessment in relation to synovial inflammation level

Annals of the Rheumatic Diseases

Volumn 69, Issue 2, 2010, Pages 450-457

  Jones, E ^a   Churchman, S M ^a   English, A ^a   Buch, M H ^a   Horner, E A ^a   Burgoyne, C H ^a   Reece, R ^a   Kinsey, S ^b   Emery, P ^a   McGonagle, D ^a,c   Ponchel, F ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; TRANSCRIPTION FACTOR SOX9;

ADULT; AGED; ARTHROSCOPY; ARTICLE; CELL PROLIFERATION; CHONDROGENESIS; CLINICAL ARTICLE; CLONOGENESIS; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MESENCHYMAL STEM CELL; OSTEOARTHRITIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVITIS; VISUAL ANALOG SCALE;

ADULT; AGED; ARTHRITIS, RHEUMATOID; ARTHROSCOPY; CELL COUNT; CELL DIFFERENTIATION; CELLS, CULTURED; CHONDROGENESIS; CYTOKINES; FEMALE; HUMANS; MALE; MESENCHYMAL STEM CELLS; MIDDLE AGED; OSTEOARTHRITIS; PHENOTYPE; SEVERITY OF ILLNESS INDEX; SYNOVITIS;

EID: 75749128260     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2008.106435     Document Type: Article

References (54)

1. Brittberg M, Lindahl A, Nilsson A, et al. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 1994;331:889-95.
2. Saris DBF, Vanlauwe J, Victor J, et al. Characterized chondrocyte implantation results in better structural repair when treating symptomatic cartilage defects of the knee in a randomized controlled trial versus microfracture. Am J Sports Med 2008;36:235-46.
3. Nesic D, Whiteside R, Brittberg M, et al. Cartilage tissue engineering for degenerative joint disease. Adv Drug Delivery Rev 2006;58:300-22.
4. Murphy JM, Fink DJ, Hunziker EB, et al. Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum 2003;10:3464-74.
5. Wakitani S, Goto T, Pineda SJ, et al. Mesenchymal cell-based repair of large, fullthickness defects of articular-cartilage. J Bone Joint Surg (Am) 1994;76A:579-92.
6. Kafienah W, Mistry S, Dickinson SC, et al. Three-dimensional cartilage tissue engineering using adult stem cells from osteoarthritis patients. Arthritis Rheum 2007;56:177-87.
7. Sakaguchi Y, Sekiya I, Yagishita K, et al. Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum 2005;52:2521-9.
8. Nagase T, Muneta T, Ju YJ, et al. Analysis of the chondrogenic potential of human synovial stem cells according to harvest site and culture parameters in knees with medial compartment osteoarthritis. Arthritis Rheum 2008;58:1389-98.
9. Tuan R. Stemming cartilage degeneration: adult mesenchymal stem cells as a cell source for articular cartilage tissue engineering. Arthritis Rheum 2006;54:3075-8.
10. De Bari C, Dell'Accio F, Tylzanowski P, et al. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 2001;44:1928-42.
11. Jones EA, English A, Henshaw K, et al. Enumeration and phenotypic characterization of synovial fluid multipotential mesenchymal progenitor cells in inflammatory and degenerative arthritis. Arthritis Rheum 2004;50:817-27.
12. Morito T, Muneta T, Hara K, et al. Synovial fluid-derived mesenchymal stem cells increase after intra-articular ligament injury in humans. Rheumatology 2008;47:1137-43.
13. Bi Y, Ehirchiou D, Kilts TM, et al. Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nat Med 2007;13:1219-27.
14. De Bari C, Dell'Accio F, Vanlauwe J, et al. Mesenchymal multipotency of adult human periosteal cells demonstrated by single-cell lineage analysis. Arthritis Rheum 2006;54:1209-21.
15. Wickham MQ, Erickson GR, Gimble JM, et al. Multipotent stromal cells derived from the infrapatellar fat pad of the knee. Clin Orthop Rel Res 2003;412:196-212.
16. English A, Jones EA, Corscadden D, et al. A comparative assessment of cartilage and joint fat pad as a potential source of cells for autologous therapy development in knee osteoarthritis. Rheumatology 2007;46:1676-83.
17. Djouad F, Bony C, Häupl T, et al. Transcriptional profiles discriminate bone marrowderived and synovium-derived mesenchymal stem cells. Arthritis Res Ther 2005;7:1304-15.
18. Jones E, Crawford A, English A, et al. Synovial fluid mesenchymal stem cells in health and early osteoarthritis: detection and functional evaluation at the single-cell level. Arthritis Rheum 2008;58:1731-40.
19. Li XL, Makarov SS. An essential role of NF-kappa B in the "tumor-like" phenotype of arthritic synoviocytes. PNAS 2006;103:17432-7.
20. Hunziker EB, Rosenberg LC. Repair of partial-thickness defects in articular cartilage: cell recruitment from the synovial membrane. J Bone Joint Surg (Am) 1996;78A:721-33.
21. Francis-West PH, Parish J, Lee K, et al. BMP/GDF-signalling interactions during synovial joint development. Cell Tissue Res 1999;296:111-19.
22. De Bari C, Dell'Accio F, Luyten FP. Failure of in vitro-differentiated mesenchymal stem cells from the synovial membrane to form ectopic stable cartilage in vivo. Arthritis Rheum 2004;50:142-50.
23. Murakami S, Lefebvre V, de Crombrugghe B. Potent inhibition of the master chondrogenic factor Sox9 gene by interleukin-1 and tumor necrosis factor-alpha. J Biol Chem 2000;275:3687-92.
24. Gilbert L, He XF, Farmer P, et al. Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2 alpha A) is inhibited by tumor necrosis factor-alpha. J Biol Chem 2002;277:2695-701.
25. Lories RJU, Derese I, De Bari C, et al. Evidence for uncoupling of inflammation and joint remodeling in a mouse model of spondylarthritis. Arthritis Rheum 2007;56:489-97.
26. Reece RJ, Canete JD, Parsons WJ, et al. Distinct vascular patterns of early synovitis in psoriatic, reactive, and rheumatoid arthritis. Arthritis Rheum 1999;42:1481-4.
27. Buch MH, Reece RJ, Quinn MA, et al. The value of synovial cytokine expression in predicting the clinical response to TNF antagonist therapy (infliximab). Rheumatology 2008;47:1469-75.
28. Verburg R, Flierman R, Sont J, et al. The outcome of intensive immunosuppression and autologous stem cell transplantation in patients with severe rheumatoid arthritis is associated with the composition of synovial T cell infiltration. Ann Rheum Dis 2005;64:1397-405.
29. Burgoyne C, Field S, Brown AK, et al. Abnormal T-cell differentiation persists in rheumatoid arthritis patients in clinical remission and predicts relapse. Ann Rheum Dis 2008;67:750-7.
30. Cunnane G, Bjork L, Ulfgren AK, et al. Quantitative analysis of synovial membrane inflammation: a comparison between automated and conventional microscopic measurements. Ann Rheum Dis 1999;58:493- 9.
31. De Bari C, Dell'Accio F, Karystinou A, et al. A biomarker-based mathematical model to predict bone-forming potency of human synovial and periosteal mesenchymal stem cells. Arthritis Rheum 2008;58:240-50.
32. Lindblad S, Hedfors E. Intraarticular variation in synovitis: local macroscopic and microscopic signs of inflammatory activity are significantly correlated. Arthritis Rheum 1985;28:977-86.
33. Haringman JJ, Gerlag DM, Zwinderman AH, et al. Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis. Ann Rheum Dis 2005;64:834-8.
34. Bianco P, Robey PG, Simmons PJ. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2008;2:313-9.
35. Grogan SP, Barbero A, Diaz-Romero J, et al. Identification of markers to characterize and sort human articular chondrocytes with enhanced in vitro chondrogenic capacity. Arthritis Rheum 2007;56:586-95.
36. Fickert S, Fiedler J, Brenner RE. Identification, quantification and isolation of mesenchymal progenitor cells from osteoarthritic synovium by fluorescence automated cell sorting. Osteoarthr Cartil 2003;11:790-800.
37. Sekiya I, Vuoristo JT, Larson BL, et al. In vitro cartilage formation by human adult stem cells from bone marrow stroma defines the sequence of cellular and molecular events during chondrogenesis. PNAS 2002;99:4397-402.
38. Sitcheran R, Cogswell PC, Baldwin AS. NF-kappa B mediates inhibition of mesenchymal cell differentiation through a posttranscriptional gene silencing mechanism. Genes Dev 2003;17:2368-73.
39. Tetlow LC, Woolley DE. Comparative immunolocalization studies of collagenase 1 and collagenase 3 production in the rheumatoid lesion, and by human chondrocytes and synoviocytes in vitro. Br J Rheum 1998;37:64-70.
40. Ohshima S, Kuchen S, Seemayer CA, et al. Galectin 3 and its binding protein in rheumatoid arthritis. Arthritis Rheum 2003;48:2788-95.
41. Baier A, Meineckel I, Gay S, et al. Apoptosis in rheumatoid arthritis. Curr Opin Rheum 2003;15:274-9.
42. Aidinis V, Plows D, Haralambous S, et al. Functional analysis of an arthritogenic synovial fibroblast. Arthritis Res Ther 2003;5:R140-57.
43. Parsonage G, Falciani F, Burman A, et al. Global gene expression profiles in fibroblasts from synovial, skin and lymphoid tissue reveals distinct cytokine and chemokine expression patterns. Thromb Haemost 2003;90:688-97.
44. Djouad F, Fritz V, Apparailly F, et al. Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis. Arthritis Rheum 2005;52:1595- 603.
45. Kastrinaki MC, Spanoudakis M, Sidiropoulos P, et al. Bone marrow mesenchymal stem cell properties in patients with rheumatoid arthritis. Ann Rheum Dis 2006;65:A37-8.
46. Dudics V, Kunstar A, Kovacs J, et al. Chondrogenic potential of mesenchymal stem cells from patients with rheumatoid arthritis and osteoarthritis: measurements in a microculture system. Cells Tissues Organs 2009;189:307-16.
47. Firestein GS. Invasive fibroblast-like synoviocytes in rheumatoid arthritis: passive responders or transformed aggressors? Arthritis Rheum1996;39:1781-90.
48. Ostergaard M, Ejbjerg B, Stoltenberg M, et al. Quantitative magnetic resonance imaging as marker of synovial membrane regeneration and recurrence of synovitis after arthroscopic knee joint synovectomy: a one year follow up study. Ann Rheum Dis 2001;60:233-6.
49. Boquest AC, Noer A, Collas P. Epigenetic programming of mesenchymal stem cells from human adipose tissue. Stem Cell Rev 2006;2:319-29.
50. Jo CH, Ahn HJ, Kim HJ, et al. Surface characterization and chondrogenic differentiation of mesenchymal stromal cells derived from synovium. Cytotherapy 2007;9:316-27.
51. Henderson KJ, Edwards JCW, Worrall JG. Expression of CD44 in normal and rheumatoid synovium and cultured synovial fibroblasts. Ann Rheum Dis 1994;53:729-34.
52. Hart DA, Kydd AS, Frank CB, et al. Tissue repair in rheumatoid arthritis: challenges and opportunities in the face of a systemic inflammatory disease. Best Pract Res Clin Rheumatol 2004;18:187- 202.
53. Rau R, Herborn G, Wassenberg S. Healing of erosive changes in rheumatoid arthritis. Clin Exp Rheumatol 2004;22:S44-9.
54. Shealy DJ, Wooley PH, Emmell E, et al. Anti-TNF-alpha antibody allows healing of joint damage in polyarthritic transgenic mice. Arthritis Res 2002;4:5-9.